BCL2L10 and cancer: Our results are in very good agreement with two studies in the literature that linked resistance of cancer cell lines established from solid tumor and myeloid leukemia to various chemotherapeutic agents and overexpression of BCL2L10 both at the mRNA and protein level [34, 35].